Your browser is no longer supported. Please, upgrade your browser.
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E38.12 EPS (ttm)6.37 Insider Own0.67% Shs Outstand289.52M Perf Week1.82%
Market Cap70.15B Forward P/E19.57 EPS next Y12.40 Insider Trans-0.71% Shs Float285.26M Perf Month-6.38%
Income1.86B PEG3.77 EPS next Q2.45 Inst Own87.90% Short Float1.07% Perf Quarter-1.47%
Sales19.90B P/S3.53 EPS this Y-27.70% Inst Trans-0.05% Short Ratio2.26 Perf Half Y-5.97%
Book/sh83.35 P/B2.91 EPS next Y-3.81% ROA3.40% Target Price267.80 Perf Year2.25%
Cash/sh10.99 P/C22.08 EPS next 5Y10.10% ROE7.70% 52W Range226.15 - 267.37 Perf YTD-2.99%
Dividend3.32 P/FCF22.56 EPS past 5Y-4.10% ROI3.30% 52W High-9.22% Beta0.74
Dividend %1.37% Quick Ratio0.90 Sales past 5Y10.70% Gross Margin47.30% 52W Low7.33% ATR4.02
Employees72000 Current Ratio1.20 Sales Q/Q26.80% Oper. Margin12.70% RSI (14)45.18 Volatility1.41% 1.68%
OptionableYes Debt/Eq0.73 EPS Q/Q77.00% Profit Margin9.40% Rel Volume0.61 Prev Close238.45
ShortableYes LT Debt/Eq0.65 EarningsNov 04 BMO Payout51.10% Avg Volume1.35M Price242.73
Recom2.20 SMA20-1.16% SMA50-2.78% SMA200-2.39% Volume836,549 Change1.79%
Aug-06-21Downgrade JP Morgan Overweight → Neutral $265
May-25-21Initiated Barclays Equal Weight $270
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $297
Dec-15-20Downgrade Wells Fargo Overweight → Equal Weight $265
Jul-09-20Upgrade Barclays Equal Weight → Overweight $300
Jun-01-20Resumed Goldman Buy $278
Mar-05-20Initiated Citigroup Neutral $260
Feb-07-20Downgrade Raymond James Strong Buy → Outperform $283
Feb-07-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20Downgrade Cowen Outperform → Market Perform
Feb-06-20Downgrade Cowen Outperform → Market Perform
Jan-08-20Downgrade Barclays Overweight → Equal Weight $275
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Oct-18-21 06:50AM  
Oct-15-21 10:10AM  
Oct-14-21 11:04AM  
Oct-07-21 08:02AM  
06:45AM  
Oct-06-21 07:09AM  
06:50AM  
Oct-05-21 08:19AM  
07:10AM  
Oct-04-21 04:15PM  
11:31AM  
Sep-28-21 11:48AM  
Sep-25-21 11:15AM  
Sep-22-21 06:50AM  
Sep-21-21 06:50AM  
Sep-17-21 06:49AM  
Sep-04-21 08:25AM  
Sep-03-21 09:38AM  
Aug-31-21 10:53AM  
Aug-27-21 07:00AM  
Aug-26-21 04:45PM  
11:17AM  
10:51AM  
09:02AM  
Aug-25-21 04:10PM  
01:46PM  
06:50AM  
Aug-21-21 08:22AM  
Aug-19-21 04:15PM  
12:40PM  
06:05AM  
Aug-17-21 03:54PM  
Aug-16-21 09:50AM  
Aug-11-21 06:45AM  
06:00AM  
Aug-10-21 01:18PM  
Aug-09-21 10:49AM  
Aug-05-21 02:31PM  
11:54AM  
11:21AM  
07:25AM  
06:00AM  
06:00AM  
Aug-04-21 09:02AM  
Aug-02-21 10:24AM  
Jul-29-21 05:13PM  
11:13AM  
06:50AM  
Jul-27-21 04:15PM  
06:50AM  
Jul-23-21 01:11PM  
11:46AM  
Jul-20-21 06:55AM  
Jul-19-21 08:55AM  
Jul-16-21 04:47AM  
Jul-12-21 09:44AM  
06:50AM  
Jul-07-21 06:55AM  
Jul-02-21 01:40PM  
Jun-30-21 06:11PM  
01:42PM  
Jun-24-21 10:17AM  
Jun-23-21 06:55AM  
Jun-22-21 06:57AM  
Jun-17-21 04:30PM  
08:03AM  
Jun-16-21 06:32AM  
Jun-14-21 02:17PM  
Jun-11-21 06:50AM  
Jun-10-21 06:45AM  
Jun-08-21 06:55AM  
Jun-07-21 10:29AM  
Jun-02-21 06:55AM  
May-31-21 10:45AM  
May-26-21 04:15PM  
06:50AM  
May-25-21 06:50AM  
06:20AM  
May-19-21 08:05AM  
May-18-21 09:08AM  
06:51AM  
06:00AM  
May-13-21 06:24PM  
06:00AM  
May-11-21 01:11PM  
May-07-21 01:52AM  
May-06-21 12:53PM  
12:25PM  
08:00AM  
07:31AM  
07:30AM  
06:15AM  
06:15AM  
06:00AM  
06:00AM  
May-05-21 08:38AM  
May-03-21 12:25PM  
Apr-29-21 07:26PM  
05:04PM  
06:50AM  
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hickey DavidEVP & President, Life SciencesSep 08Sale260.00500130,0003,586Sep 08 05:40 PM
RIMEL REBECCA WDirectorSep 08Sale260.00500130,00010,618Sep 08 10:47 AM
Spoerel Thomas JVP Controller & Chief Acct OffSep 08Sale260.0026769,4201,018Sep 08 05:52 PM
Lim James CExecutive Vice PresidentSep 03Option Exercise134.7314,5841,964,90234,352Sep 07 09:46 AM
Lim James CExecutive Vice PresidentSep 03Sale257.446,9561,790,75319,768Sep 07 09:46 AM
RIMEL REBECCA WDirectorSep 03Sale257.10500128,55011,118Sep 03 10:01 AM
RIMEL REBECCA WDirectorSep 02Sale254.0024461,97611,618Sep 03 08:36 AM
RIMEL REBECCA WDirectorAug 30Sale252.0020752,16411,862Aug 31 08:54 AM
Fraser ClaireDirectorAug 18Sale251.5838797,36120,220Aug 18 12:29 PM
RIMEL REBECCA WDirectorAug 17Sale252.0020752,16412,069Aug 18 12:23 PM
Spoerel Thomas JVP Controller & Chief Acct OffAug 06Sale242.3026664,4521,285Aug 09 01:23 PM
Lim James CExecutive Vice PresidentMay 28Sale241.683,429828,721801Jun 02 08:50 AM
Fraser ClaireDirectorMay 27Sale241.3639094,13020,607May 28 09:57 AM
Goette RolandEVP and President, EMEANov 23Option Exercise76.643,485267,09010,085Nov 24 04:52 PM
Goette RolandEVP and President, EMEANov 23Sale230.10930213,9937,994Nov 24 04:52 PM